Cargando…

Trends in Malignant Glioma Monoclonal Antibody Therapy

Although new passive and active immunotherapy methods are emerging, unconjugated monoclonal antibodies remain the only kind of biological preparations approved for high-grade glioma therapy in clinical practice. In this review, we combine clinical and experimental data discussion. As antiangiogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chekhonin, Ivan, Gurina, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997917/
http://dx.doi.org/10.2174/1573394711888150917142941